A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.

A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
复制标题

DOI:
10.1038/s41598-021-97405-1
复制
发表时间:
2021-09-13
期刊:
影响因子:
4.6
通讯作者:
Smith RL
Smith RL
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Chennampally P;Sayed-Zahid A;Soundararajan P;Sharp J;Cox GA;Collins SD;Smith RL

文献摘要

参考文献

被引文献

相似文献

TAR DNA结合蛋白-43(TDP-43)在肌萎缩侧索硬化症影响的运动神经元的泛素化内含物中积累,导致运动神经元变性,运动功能丧失,最终死亡。雷帕霉素是一种mTOR抑制剂和常用的免疫抑制药物,已显示可增加肌萎缩侧索硬化症(ALS)影响的运动神经元的存活率。在这里,我们提出了一个转基因,TDP-43-A315 T,表达ALS表型的小鼠模型,并证明存在泛素化的细胞质TDP-43聚集体,在体外分化后28天细胞死亡> 80%。来自该小鼠模型的胚胎干细胞用于研究使用新型微流体雷帕霉素浓度梯度发生器的TDP-43聚集体的发作、进展和治疗性补救。使用微流体装置的结果显示,在0.4-1.0 µM的雷帕霉素剂量范围内,ALS影响的运动神经元存活率可增加40.44%。
TAR DNA-binding protein-43 (TDP-43) is known to accumulate in ubiquitinated inclusions of amyotrophic lateral sclerosis affected motor neurons, resulting in motor neuron degeneration, loss of motor functions, and eventually death. Rapamycin, an mTOR inhibitor and a commonly used immunosuppressive drug, has been shown to increase the survivability of Amyotrophic Lateral Sclerosis (ALS) affected motor neurons. Here we present a transgenic, TDP-43-A315T, mouse model expressing an ALS phenotype and demonstrate the presence of ubiquitinated cytoplasmic TDP-43 aggregates with > 80% cell death by 28 days post differentiation in vitro. Embryonic stem cells from this mouse model were used to study the onset, progression, and therapeutic remediation of TDP-43 aggregates using a novel microfluidic rapamycin concentration gradient generator. Results using a microfluidic device show that ALS affected motor neuron survival can be increased by 40.44% in a rapamycin dosage range between 0.4-1.0 µM.
DOI: 10.1016/j.mcn.2013.07.007
发表时间: 2013-09
期刊: Molecular and cellular neurosciences
影响因子: --
作者:
Burkhardt MF;Martinez FJ;Wright S;Ramos C;Volfson D;Mason M;Garnes J;Dang V;Lievers J;Shoukat-Mumtaz U;Martinez R;Gai H;Blake R;Vaisberg E;Grskovic M;Johnson C;Irion S;Bright J;Cooper B;Nguyen L;Griswold-Prenner I;Javaherian A
通讯作者: Javaherian A
DOI: 10.1016/j.neurobiolaging.2009.12.020
发表时间: 2011-03
影响因子: 4.2
作者:
Lai, Shiao-Lin;Abramzon, Yevgeniya;Schymick, Jennifer C.;Stephan, Dietrich A.;Dunckley, Travis;Dillman, Allissa;Cookson, Mark;Calvo, Andrea;Battistini, Stefania;Giannini, Fabio;Caponnetto, Claudia;Luigi, Giovanni;Spataro, Rossella;Monsurro, Maria Rosaria;Tedeschi, Gioacchino;Marinou, Kalliopi;Sabatelli, Mario;Conte, Amelia;Mandrioli, Jessica;Sola, Patrizia;Salvi, Fabrizio;Bartolomei, Ilaria;Lombardo, Federica;Mora, Gabriele;Restagno, Gabriella;Chio, Adriano;Traynor, Bryan J.
通讯作者: Traynor, Bryan J.
DOI: 10.1038/ncomms6845
发表时间: 2015-01-05
影响因子: 16.6
作者:
Cohen, Todd J.;Hwang, Andrew W.;Restrepo, Clark R.;Yuan, Chao-Xing;Trojanowski, John Q.;Lee, Virginia M. Y.
通讯作者: Lee, Virginia M. Y.
DOI: 10.1126/science.1166066
发表时间: 2009-02-27
期刊: SCIENCE
影响因子: 56.9
作者:
Kwiatkowski, T. J., Jr.;Bosco, D. A.;Brown, R. H., Jr.
通讯作者: Brown, R. H., Jr.
DOI: 10.1093/bfgp/ell015
发表时间: 2006-03-01
期刊: Briefings in Functional Genomics & Proteomics
影响因子: --
作者:
Law, Warren J.;Cann, Kendra L.;Hicks, Geoffrey G.
通讯作者: Hicks, Geoffrey G.